Market Overview:
The global point of care lipid test market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. In addition, technological advancements in point-of-care lipid testing are also contributing to the growth of this market. On the basis of type, the global point-of-care lipid test market is segmented into PoC lipid test instruments and PoC lipid test consumables. The PoC lipid test instruments segment is further subsegmented into desktop analyzers, handheld analyzers, and others. The desktop analyzers segment accounted for the largest share of the global PoC Lipid Test Instruments Market in 2017 owing to their wide adoption across hospitals and clinics worldwide. However, with technological advancements in portable devices such as handheld analyzers over traditional desktop devices; this segment is expected to witness high growth during the forecast period from 2018 to 2030.
Product Definition:
Point of care lipid tests are used to measure cholesterol and triglyceride levels in the blood. These tests can be performed in a doctor's office or other healthcare setting, which is why they are often referred to as "point of care" tests. Cholesterol and triglycerides are two types of lipids, or fats, that can be found in the blood. Elevated levels of either cholesterol or triglycerides can indicate a risk for heart disease. Point of care lipid tests can help doctors determine whether someone needs treatment for high cholesterol or high triglycerides.
PoC Lipid Test Instrument:
PoC lipid test instrument is used for the rapid and accurate detection of lipid level in blood, serum or plasma. It provides results within a minute or less than that. PoC lipid testing instruments are easy to use and provide fast results which help medical personals to take appropriate decision regarding treatment immediately.
PoC Lipid Test Consumables:
PoC lipid test consumables are used for the detection of high risk lipids such as cholesterol, triglycerides and phospholipids in a patient's blood. The PoC lipid test consumables market is expected to witness lucrative growth over the forecast period owing to increasing prevalence of cardiovascular diseases (CVD) globally. According to WHO, CVDs contribute 6th leading cause of death worldwide with 17.9 million deaths in 2010 and 31% increase since 1990.
Application Insights:
Hyperlipidemia dominated the global PoC lipid test market in terms of revenue in 2017. This is attributed to the increasing prevalence of hyperlipidemia and growing demand for point-of-care testing.
Regional Analysis:
North America dominated the global point of care lipid test market in 2017. The presence of well-established healthcare facilities, advanced diagnostic technologies and increasing prevalence of target diseases are some factors responsible for its large share. Moreover, the high cost of these tests is another factor that can be attributed to its large share.
Asia Pacific is expected to grow at a lucrative rate during the forecast period owing to an increase in patient awareness levels regarding early diagnosis coupled with rising disposable income and improving standard medical infrastructure in this region. Furthermore, government initiatives such as “HIV/AIDS Prevention & Care Initiative†by India's National Aids Control Programme (NACP) are also contributing towards PoC Lipid Test market growth in Asia Pacific region.
Growth Factors:
- Increasing prevalence of lifestyle diseases such as obesity and diabetes, which leads to an increase in the demand for Point of Care Lipid Test.
- Growing geriatric population, who are more susceptible to lifestyle diseases, drives the demand for Point of Care Lipid Test market.
- Technological advancements in Point of Care Lipid Test result in better accuracy and efficiency, thereby driving the market growth.
- Rising awareness about early diagnosis and treatment options for various lipid-related disorders fuels the growth of this market segment .
Scope Of The Report
Report Attributes
Report Details
Report Title
Point of Care Lipid Test Market Research Report
By Type
PoC Lipid Test Instrument, PoC Lipid Test Consumables
By Application
Hyperlipidemia, Hypertriglyceridemia, Familial Hypercholesterolemia, Hyperlipoproteinemia, Tangier Disease, Others
By Companies
Abaxis Inc., Roche Diagnostics, Alere Inc., Polymer Technology Systems, Samsung Electronics Corporation
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
162
Number of Tables & Figures
114
Customization Available
Yes, the report can be customized as per your need.
Global Point of Care Lipid Test Market Report Segments:
The global Point of Care Lipid Test market is segmented on the basis of:
Types
PoC Lipid Test Instrument, PoC Lipid Test Consumables
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hyperlipidemia, Hypertriglyceridemia, Familial Hypercholesterolemia, Hyperlipoproteinemia, Tangier Disease, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abaxis Inc.
- Roche Diagnostics
- Alere Inc.
- Polymer Technology Systems
- Samsung Electronics Corporation
Highlights of The Point of Care Lipid Test Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- PoC Lipid Test Instrument
- PoC Lipid Test Consumables
- By Application:
- Hyperlipidemia
- Hypertriglyceridemia
- Familial Hypercholesterolemia
- Hyperlipoproteinemia
- Tangier Disease
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Point of Care Lipid Test Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A Point of Care Lipid Test is a quick and easy way to measure your blood lipid levels.
Some of the key players operating in the point of care lipid test market are Abaxis Inc., Roche Diagnostics, Alere Inc., Polymer Technology Systems, Samsung Electronics Corporation.
The point of care lipid test market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Point of Care Lipid Test Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Point of Care Lipid Test Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Point of Care Lipid Test Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Point of Care Lipid Test Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Point of Care Lipid Test Market Size & Forecast, 2018-2028
4.5.1 Point of Care Lipid Test Market Size and Y-o-Y Growth
4.5.2 Point of Care Lipid Test Market Absolute $ Opportunity
Chapter 5 Global Point of Care Lipid Test Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Point of Care Lipid Test Market Size Forecast by Type
5.2.1 PoC Lipid Test Instrument
5.2.2 PoC Lipid Test Consumables
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Point of Care Lipid Test Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Point of Care Lipid Test Market Size Forecast by Applications
6.2.1 Hyperlipidemia
6.2.2 Hypertriglyceridemia
6.2.3 Familial Hypercholesterolemia
6.2.4 Hyperlipoproteinemia
6.2.5 Tangier Disease
6.2.6 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Point of Care Lipid Test Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Point of Care Lipid Test Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Point of Care Lipid Test Analysis and Forecast
9.1 Introduction
9.2 North America Point of Care Lipid Test Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Point of Care Lipid Test Market Size Forecast by Type
9.6.1 PoC Lipid Test Instrument
9.6.2 PoC Lipid Test Consumables
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Point of Care Lipid Test Market Size Forecast by Applications
9.10.1 Hyperlipidemia
9.10.2 Hypertriglyceridemia
9.10.3 Familial Hypercholesterolemia
9.10.4 Hyperlipoproteinemia
9.10.5 Tangier Disease
9.10.6 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Point of Care Lipid Test Analysis and Forecast
10.1 Introduction
10.2 Europe Point of Care Lipid Test Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Point of Care Lipid Test Market Size Forecast by Type
10.6.1 PoC Lipid Test Instrument
10.6.2 PoC Lipid Test Consumables
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Point of Care Lipid Test Market Size Forecast by Applications
10.10.1 Hyperlipidemia
10.10.2 Hypertriglyceridemia
10.10.3 Familial Hypercholesterolemia
10.10.4 Hyperlipoproteinemia
10.10.5 Tangier Disease
10.10.6 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Point of Care Lipid Test Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Point of Care Lipid Test Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Point of Care Lipid Test Market Size Forecast by Type
11.6.1 PoC Lipid Test Instrument
11.6.2 PoC Lipid Test Consumables
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Point of Care Lipid Test Market Size Forecast by Applications
11.10.1 Hyperlipidemia
11.10.2 Hypertriglyceridemia
11.10.3 Familial Hypercholesterolemia
11.10.4 Hyperlipoproteinemia
11.10.5 Tangier Disease
11.10.6 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Point of Care Lipid Test Analysis and Forecast
12.1 Introduction
12.2 Latin America Point of Care Lipid Test Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Point of Care Lipid Test Market Size Forecast by Type
12.6.1 PoC Lipid Test Instrument
12.6.2 PoC Lipid Test Consumables
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Point of Care Lipid Test Market Size Forecast by Applications
12.10.1 Hyperlipidemia
12.10.2 Hypertriglyceridemia
12.10.3 Familial Hypercholesterolemia
12.10.4 Hyperlipoproteinemia
12.10.5 Tangier Disease
12.10.6 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Point of Care Lipid Test Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Point of Care Lipid Test Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Point of Care Lipid Test Market Size Forecast by Type
13.6.1 PoC Lipid Test Instrument
13.6.2 PoC Lipid Test Consumables
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Point of Care Lipid Test Market Size Forecast by Applications
13.10.1 Hyperlipidemia
13.10.2 Hypertriglyceridemia
13.10.3 Familial Hypercholesterolemia
13.10.4 Hyperlipoproteinemia
13.10.5 Tangier Disease
13.10.6 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Point of Care Lipid Test Market: Competitive Dashboard
14.2 Global Point of Care Lipid Test Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abaxis Inc.
14.3.2 Roche Diagnostics
14.3.3 Alere Inc.
14.3.4 Polymer Technology Systems
14.3.5 Samsung Electronics Corporation
